Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients

Antzeko izenburuak

• The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
  nork: van Damme, N, et al.
  Argitaratua: (2002)
• Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
  nork: De Rycke, L, et al.
  Argitaratua: (2003)
• Sensitivity of ANA indirect immunofluorescence testing for the detection of anti-ENA antibodies
  nork: Hoffman, IEA, et al.
  Argitaratua: (2002)
• Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
  nork: De Rycke, L, et al.
  Argitaratua: (2005)
• Infliximab induced anti-dsDNA: characteristics of autoantibody response
  nork: Charles, PJ, et al.
  Argitaratua: (2002)